GSK3 inactivation is involved in mitochondrial complex IV defect in transforming growth factor (TGF) Β1-induced senescence

Experimental Cell Research

Volumn 318, Issue 15, 2012, Pages 1808-1819

  Byun, Hae Ok ^a   Jung, Hyun Jung ^a   Seo, Yong Hak ^a   Lee, Young Kyoung ^a   Hwang, Sung Chul ^a   Seong Hwang, Eun ^b   Yoon, Gyesoon ^a  

^a Ajou University School of Medicine   (South Korea)

^b University of Seoul   (South Korea)

Author keywords

Complex IV; GSK3; Reactive oxygen species; Senescence; TGF 1

Indexed keywords

2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; ACETYLCYSTEINE; COMPLEX IV 6B; CYTOCHROME C OXIDASE; GLYCOGEN SYNTHASE KINASE 3; OXIDOREDUCTASE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL RESPIRATION; CONTROLLED STUDY; CYTOSOL; ENZYME BINDING; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE SILENCING; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOLECULAR MECHANICS; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SENESCENCE;

EID: 84863785173     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.04.012     Document Type: Article

References (63)

1. Pardali K., Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 2007, 1775:21-62.
2. Rahimi R.A., Leof E.B. TGF-beta signaling: a tale of two responses. J. Cell. Biochem. 2007, 102:593-608.
3. Massagué J., Gomis R.R. The logic of TGFbeta signaling. FEBS Lett. 2006, 580:2811-2820.
4. Hannon G.J., Beach D. p15Ink4b is a potential effector of TGF-Β-induced cell cycle arrest. Nature 1994, 371:257-261.
5. Pardali K., Kurisaki A., Moren A., ten Dijke P., Kardassis D., Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J. Biol. Chem. 2000, 275:29244-29256.
6. Siegel P.M., Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 2003, 3:807-821.
7. Zhao H., Patra A., Tanaka Y., Li L.C., Dahiya R. Transforming growth factor-beta(s) and their receptors in aging rat prostate. Biochem. Biophys. Res. Commun. 2002, 294:464-469.
8. 2 stress triggers a release of transforming growth factor-beta 1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J. Biol. Chem. 2001, 276:2531-2537.
9. Katakura Y., Nakata E., Miura T., Shirahata S. Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem. Biophys. Res. Commun. 1999, 255:110-115.
10. Kordon E.C., McKnight R.A., Jhappan C., Hennighausen L., Merlino G., Smith G.H. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev. Biol. 1995, 168:47-61.
11. Katakura Y., Nakata E., Miura T., Shirahata S. Transforming growth factor beta triggers two independent-senescence programs in cancer cells. Biochem. Biophys. Res. Commun. 1999, 255:110-115.
12. Warner B.J., Blain S.W., Seoane J., Massague J. Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. Mol. Cell. Biol. 1999, 19:5913-5922.
13. Massague J., Blain S.W., Lo R.S. TGF beta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
14. Li C.Y., Suardet L., Little J.B. Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J. Biol. Chem. 1995, 270:4971-4974.
15. Sanchez A., Alvarez A.M., Benito M., Fabregat I. Apoptosis induced by transforming growth factor-beta in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates. J. Biol. Chem. 1996, 271:7416-7422.
16. Herrera B., Alvarez A.M., Sanchez A., Fernandez M., Roncero C., Benito M., Fabregat I. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J. 2001, 15:741-751.
17. Islam K.N., Kayanoki Y., Kaneto H., Suzuki K., Asahi M., Fujii J., Taniguchi N. TGF-beta1 triggers oxidative modifications and enhances apoptosis in HIT cells through accumulation of reactive oxygen species by suppression of catalase and glutathione peroxidase. Free Rad. Biol. Med. 1997, 22:1007-1017.
18. Yoon Y.S., Lee J.H., Hwang S.C., Choi K.S., Yoon G. TGF Β1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells. Oncogene 2005, 24:1895-1903.
19. Linnane A.W., Marzuki S., Ozawa T., Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1989, 1:642-645.
20. Wallace D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases?. Science 1992, 256:628-632.
21. Shigenaga M.K., Hagan T.M., Ames B.N. Oxidative damage and mitochondrial decay in ageing. Proc. Natl. Acad. Sci. USA 1994, 91:10771-10778.
22. Nagley P., Wei Y.H. Ageing and mammalian mitochondrial genetics. Trends Genet. 1998, 14:513-517.
23. Harman D. The biologic clock: the mitochondria?. J. Am. Geriatr. Soc. 1972, 20:145-147.
24. Ugidos A., Nystrom T., Caballero A. Perspectives on the mitochondrial etiology of replicative aging in yeast. Exp. Gerontol. 2010, 45:512-515.
25. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
26. Lee A.C., Fenster B.E., Ito H., Takeda K., Bae N.S., Hirai T., Yu Z.X., Ferrans V.J., Howard B.H., Finkel T. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 1999, 274:7936-7940.
27. Collado M., Medema R.H., Garcia-Cao I., Dubuisson M.L., Barradas M., Glassford J., Rivas C., Burgering B.M., Serrano M., Lam E.W. Inhibition of the phosphoinositide 3-kinase pathway induces a senescence-like arrest mediated by p27Kip1. J. Biol. Chem. 2000, 275:21960-21968.
28. Poynter M.E., Daynes R.A. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappa B signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem. 1998, 273:32833-32841.
29. Supakar P.C., Jung M.H., Song C.S., Chatterjee B., Roy A.K. Nuclear factor kappa B functions as a negative regulator for the rat androgen receptor gene and NF-kappa B activity increases during the age-dependent desensitization of the liver. J. Biol. Chem. 1995, 270:837-842.
30. Macip S., Igarashi M., Berggren P., Yu J., Lee S.W., Aaronson S.A. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 2003, 23:8576-8585.
31. Macip S., Igarashi M., Fang L., Chen A., Pan Z., Lee S.W., Aaronson S.A. Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J. 2002, 21:2180-2188.
32. Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., Lowe S.W. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 2000, 109:335-346.
33. Bringold F., Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol. 2000, 35:317-329.
34. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., Peacocke M., Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 1995, 92:9363-9367.
35. Seo Y.H., Jung H.J, Shin H.T., Kim Y.M., Yim H., Chung H.Y., Lim I.K., Yoon G. Enhanced glycogenesis is involved in cellular senescence via GSK3/GS modulation. Aging Cell 2008, 7:894-907.
36. Villani G, Attardi G. In vivo measurements of respiration control by cytochrome c oxidase and in situ analysis of oxidative phosphorylation. Methods Cell Biol. 2001, 65:119-131.
37. Yoon Y.S., Byun H.O., Cho H., Kim B.K., Yoon G. Complex II defect via down-regulation of iron-sulfur subunit induces mitochondrial dysfunction and cell cycle delay in iron chelation-induced senescence-associated growth arrest. J. Biol. Chem. 2003, 278:51577-51586.
38. Rahimi R.A., Leof E.B. TGF-beta signaling: a tale of two responses. J. Cell. Biochem. 2007, 102:593-608.
39. Coghlan M.P., Culbert A.A., Cross D.A., Corcoran S.L., Yates J.W., Pearce N.J., Rausch O.L., Murphy G.J., Carter P.S., Cox L.R., Mills D., Brown M.J., Haigh D., Ward R.W., Smith D.G., Murray K.J., Reith A.D., Holder J.C. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 2000, 7:793-803.
40. Bijur G.N., Jope R.S. Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria. Neuroreport 2003, 14:2415-2419.
41. Tsukihara T., Aoyama H., Yamashita E., Tomizaki T., Yamaguchi H., Shinzawa-Itoh K., Nakashima R., Yaono R., Yoshikawa S. The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A. Science 1996, 272:1136-1144.
42. Reinders J., Wagner K., Zahedi R.P., Stojanovski D., Eyrich B., van der Laan M., Rehling P., Sickmann A., Pfanner N., Meisinger C. Profiling phosphoproteins of yeast mitochondria reveals a role of phosphorylation in assembly of the ATP synthase. Mol. Cell. Proteomics 2007, 6:1896-1906.
43. Rhee S., Chae H., Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Rad. Biol. Med. 2005, 38:1543-1552.
44. Embi N., Rylatt D.B., Cohen P. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 1980, 107:519-527.
45. Rylatt D.B., Aitken A., Bilham T., Condon G.D., Embi N., Cohen P. Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phosphorylase kinase. Eur. J. Biochem. 1980, 107:529-537.
46. Forde J.E., Dale T.C. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol. Life Sci. 2007, 64:1930-1944.
47. Takashima A GSK-3 is essential in the pathogenesis of Alzheimer's disease. J. Alzheimers. Dis 2006, 9:309-317.
48. Eldar-Finkelman H., Ilouz R. Challenges and oppotunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment. Expert Opin. Investig. Drugs 2003, 12:1511-1519.
49. Jope R.S., Yuskaitis C.J., Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 2007, 32:577-595.
50. Ban K.C., Singh H., Krishnan R., Seow H.F. GSK-3beta phosphorylation of FKHR transcription factor as a prognostic variable in acute myeloid leukemia. Leuk. Res. 2003, 27:1159-1162.
51. Shakoori A., Ougolkov A., Yu Z.W., Zhang B., Modarressi M.H., Billadeau D.D., Mai M., Takahashi Y., Minamoto T. Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation. Biochem. Biophys. Res. Commun. 2005, 334:1365-1373.
52. Cohen P., Frame S. The renaissance of GSK3. Nature Rev. Mol. Cell Biol. 2001, 2:769-776.
53. Holzenberger M., Dupont J., Ducos B., Leneuve P., Géloën A., Even P.C., Cervera P., Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187.
54. Miyauchi H., Minamino T., Tateno K., Kunieda T., Toko H., Komuro I. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004, 23:212-220.
55. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 2005, 120:449-460.
56. Kimura K.D., Tissenbaum H.A., Liu Y., Ruvkun G. Daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997, 277:942-946.
57. Kadenbach B., Huttemann M., Arnold S., Lee I., Bender E. Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. Free Radical Biol. Med. 2000, 29:211-221.
58. Kadenbach B., Ramzan R., Wen L., Vogt S. New extension of the Mitchell theory for oxidative phosphorylation in mitochondria of living organisms. Biochim. Biophys. Acta 2010, 1800:205-212.
59. Miyazaki T., Neff L., Tanaka S., Horne W.C., Baron R. Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J. Cell Biol. 2009, 160:709-718.
60. Ogbi M., Johnson J.A. Protein kinase c epsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning. Biochem. J. 2006, 393:191-199.
61. Prabu S.K., Anandatheerthavarada H.K., Raza H., Srinivasan S., Spear J.F., Avadhani N.G. Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J. Biol. Chem. 2006, 281:2061-2070.
62. Lee I., Salomon A.R., Ficarro S., Mathes I., Lottspeich F., Grossman L.I., Huttemann M. cAMP-dependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity. J. Biol. Chem. 2005, 280:6094-6100.
63. Fang J.K., Prabu S.K., Sepuri N.B., Raza H., Anandatheerthavarada H.K., Galati D., Spear J., Avadhani N.G. Site specific phosphorylation of cytochrome c oxidase subunits I, IVi1 and Vb in rabbit hearts subjected to ischemia/reperfusion. FEBS Lett. 2007, 581:1302-1310.